MUC16 is known to promote the progression and metastasis of a variety of malignant tumors, and the abnormal expression of MUC16 can lead to drug resistance to cytotoxic drugs and inhibition of apoptosis (Das et al., 2015). Here, MUC16 is linked to cancer.